# Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients

> **NCT03536234** · PHASE2 · UNKNOWN · sponsor: **Immune System Regulation AB** · enrollment: 52 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Triptorelin acetate depot

## Key facts

- **NCT ID:** NCT03536234
- **Lead sponsor:** Immune System Regulation AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-19
- **Primary completion:** 2021-08
- **Final completion:** 2021-12
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03536234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03536234, "Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT03536234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*